MYGN vs STE · rev $837.6M vs P/E 25, rev $5.94B
Myriad Genetics Inc (MYGN) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
MYGN currently screens at market cap $413.7M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the MYGN and STE stock pages for the full models.
Not investment advice.